Murphy Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$217K Hold
450
0.03% 203
2022
Q1
$221K Hold
450
0.03% 215
2021
Q4
$208K Buy
+450
New +$189K 0.02% 224
2019
Q2
Sell
-700
Closed -$200K 243
2019
Q1
$200K Buy
+700
New +$202K 0.03% 242

Other funds holding ELV

Murphy Capital Management's ELV Position: Q2 2022 in Review

Murphy Capital Management held its Elevance Health (ELV) position steady in Q2 2022 at 450 shares worth $217K. The position accounts for 0.03% of the portfolio, ranked #203.

Murphy Capital Management first reported a position in ELV in Q1 2019 and has held it in 4 quarters since. The position peaked at $221K in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Murphy Capital Management held 450 shares of Elevance Health worth $217K as of Q2 2022.
  • Murphy Capital Management left its Elevance Health share count unchanged in Q2 2022.
  • Elevance Health made up 0.03% of Murphy Capital Management's portfolio in Q2 2022, its #203 holding.
  • Murphy Capital Management first reported a position in Elevance Health in Q1 2019 and has held it in 4 quarters since.
  • Murphy Capital Management's Elevance Health position peaked at $221K in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Murphy Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.